Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Dementia Alzheimer's type

Recruiting

Investigational

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Asthma

Recruiting

InvestigationalNo placebo

Study of depemokimab to improve airway function in patients with type 2 eosinophilic asthma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Small cell lung cancer recurrent

Recruiting

Registered drugNo placebo

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:GSK5764227

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Study of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Mantle cell lymphoma

Recruiting

Registered drugNo placebo

Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Diffuse large B-cell lymphoma+2

Recruiting

Registered drugNo placebo

Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ivosidenib

Contact Research Centre

Myelodysplastic syndrome

Recruiting

InvestigationalNo placebo

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drug

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

IgA nephropathy

Recruiting

Registered drug

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Dupilumab

Contact Research Centre

IgA nephropathy

Recruiting

Investigational

Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 10

601 trials match your criteria

Dementia Alzheimer's type

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Asthma

Study of depemokimab to improve airway function in patients with type 2 eosinophilic asthma

Small cell lung cancer recurrent

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Non-small cell lung cancer+1

Study of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer

Mantle cell lymphoma

Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

Diffuse large B-cell lymphoma+2

Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

Cholangiocarcinoma

Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

Myelodysplastic syndrome

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

Squamous cell carcinoma of head and neck

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

IgA nephropathy

Study of felzartamab compared to placebo in adults with IgA nephropathy

Chronic obstructive pulmonary disease

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

IgA nephropathy

Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.